233275-76-8
中文名稱(chēng)
MK 0343
英文名稱(chēng)
MK 0343
CAS
233275-76-8
分子式
C19H17F2N7O
分子量
397.38
MOL 文件
233275-76-8.mol
更新日期
2023/03/20 15:41:21
233275-76-8 結(jié)構(gòu)式
基本信息
中文別名
7-環(huán)丁基-3-(2,6-二氟苯基)-6-((1-甲基-1H-1,2,4-三氮唑-5-乙基)甲氧基)-[1,2,4]三氮唑[4,3-B]噠嗪 英文別名
MK 0343MRK-409
MK-0343 >=98% (HPLC)
7-Cyclobutyl-3-(2,6-difluorophenyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-1,2,4-triazo[4,3-b]pyridazine
7-Cyclobutyl-3-(2,6-difluorophenyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-1,2,4-triazolo[4,3-b]pyridazine
1,2,4-Triazolo[4,3-b]pyridazine, 7-cyclobutyl-3-(2,6-difluorophenyl)-6-[(1-Methyl-1H-1,2,4-triazol-5-yl)Methoxy]-
物理化學(xué)性質(zhì)
密度1.57±0.1 g/cm3(Predicted)
儲(chǔ)存條件Inert atmosphere,2-8°C
溶解度DMSO：可溶10mg/mL，澄清
酸度系數(shù)(pKa)2.11±0.10(Predicted)
形態(tài)粉末
顏色白色至米色
安全數(shù)據(jù)
警示詞警告
危險(xiǎn)性描述H315-H319-H227
防范說(shuō)明P501-P210-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313-P403+P235
WGK Germany3
MK 0343價(jià)格(試劑級(jí))
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱(chēng) | CAS號(hào) | 包裝 | 價(jià)格 |
| 2025/02/08 | HY-101869 | MK 0343 MK-0343 | 233275-76-8 | 5mg | 1500元 |
| 2025/02/08 | HY-101869 | MK-0343 | 233275-76-8 | 10 mM * 1 mLin DMSO | 1650元 |
| 2025/02/08 | HY-101869 | MK 0343 MK-0343 | 233275-76-8 | 10 mg | 2500元 |
常見(jiàn)問(wèn)題列表
生物活性
MK0343 (MRK-409) 是一種口服生物可利用的 GABAA 受體亞型選擇性部分激動(dòng)劑。MK0343 是一種非鎮(zhèn)靜的抗焦慮藥物。靶點(diǎn)
Ki: 0.22 nM (rGABA A α1), 0.4 nM (rGABA A α2) , 0.21 nM (rGABA A α3), 78 nM (rGABA A α4), 0.23 nM (rGABA A α5), 980 nM (rGABA A α6)
體內(nèi)研究
MK0343 readily penetrates the brain in rats and occupies the benzodiazepine site of GABAA receptors, measured using an in vivo [
3
H]flumazenil binding assay, with an Occ
50
of 2.2?mg/kg p.o. and a corresponding plasma EC
50
of 115?ng/mL.
| Animal Model: | Male Sprague-Dawley rats (approximately 250–300g) (pharmacokinetics) |
| Dosage: | 1, 2 or 3?mg/kg |
| Administration: | Oral administration |
| Result: | Readily penetrated the brain in rats and occupies the benzodiazepine site of GABAA receptors, with an Occ 50 of 2.2?mg/kg p.o. and a corresponding plasma EC 50 of 115?ng/mL. |